[1]
|
R. Talukdar, N. Saikia, D.K. Singal, R. Tandon, Chronic pancreatitis: evolving paradigms, Pancreatology 6 (2006) 440-449.
|
[2]
|
E. Dixon, J.S. Graham, F. Sutherland, P.C. Mitchell, Splenic injury following endoscopic retrograde cholangiopancreatography: a case report and review of the literature, JSLS 8 (2004) 275-277.
|
[3]
|
N. Manciu, D.S. Beebe, P. Tran, R. Gruessner, D.E. Sutherland, K.G. Belani, Total pancreatectomy with islet cell autotransplantation: anesthetic implications, J Clin Anesth 11 (1999) 576-582.
|
[4]
|
J. Dixon, M. DeLegge, K.A. Morgan, D.B. Adams, Impact of total pancreatectomy with islet cell transplant on chronic pancreatitis management at a disease-based center, The American surgeon 74 (2008) 735-738.
|
[5]
|
D.C. Wahoff, B.E. Papalois, J.S. Najarian, D.M. Kendall, A.C. Farney, J.P. Leone, J. Jessurun, D.L. Dunn, R.P. Robertson, D.E. Sutherland, Autologous islet transplantation to prevent diabetes after pancreatic resection, Ann Surg 222 (1995) 562-575; discussion 575-569.
|
[6]
|
U.K. Bhanot, P. Moller, Mechanisms of parenchymal injury and signaling pathways in ectatic ducts of chronic pancreatitis: implications for pancreatic carcinogenesis, Lab Invest 89 (2009) 489-497.
|
[7]
|
H. Schrader, B.A. Menge, S. Schneider, O. Belyaev, A. Tannapfel, W. Uhl, W.E. Schmidt, J.J. Meier, Reduced pancreatic volume and beta-cell area in patients with chronic pancreatitis, Gastroenterology 136 (2009) 513-522.
|
[8]
|
R.M. Mitchell, M.F. Byrne, J. Baillie, Pancreatitis, Lancet 361 (2003) 1447-1455.
|
[9]
|
S. Mitnala, P.K. Pondugala, V.R. Guduru, P. Rabella, J. Thiyyari, S. Chivukula, S. Boddupalli, A.A. Hardikar, D.N. Reddy, Reduced expression of PDX-1 is associated with decreased beta cell function in chronic pancreatitis, Pancreas 39 (2010) 856-862.
|
[10]
|
A.M. Davalli, L. Scaglia, D.H. Zangen, J. Hollister, S. Bonner-Weir, G.C. Weir, Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function, Diabetes 45 (1996) 1161-1167.
|
[11]
|
Y. Cui, D.K. Andersen, Pancreatogenic diabetes: special considerations for management, Pancreatology : official journal of the International Association of Pancreatology 11 (2011) 279-294.
|
[12]
|
P.G. Lankisch, Natural course of chronic pancreatitis, Pancreatology : official journal of the International Association of Pancreatology 1 (2001) 3-14.
|
[13]
|
A.C. Bateman, S.M. Turner, K.S. Thomas, P.R. McCrudden, D.R. Fine, P.A. Johnson, C.D. Johnson, J.P. Iredale, Apoptosis and proliferation of acinar and islet cells in chronic pancreatitis: evidence for differential cell loss mediating preservation of islet function, Gut 50 (2002) 542-548.
|
[14]
|
C. Hasel, B. Rau, S. Perner, J. Strater, P. Moller, Differential and mutually exclusive expression of CD95 and CD95 ligand in epithelia of normal pancreas and chronic pancreatitis, Laboratory investigation; a journal of technical methods and pathology 81 (2001) 317-326.
|
[15]
|
C. Hasel, S. Durr, B. Rau, J. Strater, R.M. Schmid, H. Walczak, M.G. Bachem, P. Moller, In chronic pancreatitis, widespread emergence of TRAIL receptors in epithelia coincides with neoexpression of TRAIL by pancreatic stellate cells of early fibrotic areas, Laboratory investigation; a journal of technical methods and pathology 83 (2003) 825-836.
|
[16]
|
S.E. Lamhamedi-Cherradi, S. Zheng, R.M. Tisch, Y.H. Chen, Critical roles of tumor necrosis factor-related apoptosis-inducing ligand in type 1 diabetes, Diabetes 52 (2003) 2274-2278.
|
[17]
|
U.K. Bhanot, P. Moller, Mechanisms of parenchymal injury and signaling pathways in ectatic ducts of chronic pancreatitis: implications for pancreatic carcinogenesis, Laboratory investigation; a journal of technical methods and pathology 89 (2009) 489-497.
|
[18]
|
M.A. Degli-Esposti, W.C. Dougall, P.J. Smolak, J.Y. Waugh, C.A. Smith, R.G. Goodwin, The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain, Immunity 7 (1997) 813-820.
|
[19]
|
X. Chen, B. Ji, B. Han, S.A. Ernst, D. Simeone, C.D. Logsdon, NF-kappaB activation in pancreas induces pancreatic and systemic inflammatory response, Gastroenterology 122 (2002) 448-457.
|
[20]
|
A.E. Butler, J. Janson, S. Bonner-Weir, R. Ritzel, R.A. Rizza, P.C. Butler, Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes, Diabetes 52 (2003) 102-110.
|
[21]
|
M.Y. Donath, J. Storling, L.A. Berchtold, N. Billestrup, T. Mandrup-Poulsen, Cytokines and beta-cell biology: from concept to clinical translation, Endocrine reviews 29 (2008) 334-350.
|
[22]
|
R.K. Tandon, P.K. Garg, Oxidative stress in chronic pancreatitis: pathophysiological relevance and management, Antioxid Redox Signal 15 2757-2766.
|
[23]
|
P. Pavan Kumar, G. Radhika, G.V. Rao, R. Pradeep, C. Subramanyam, R. Talukdar, D.N. Reddy, M. Sasikala, Interferon gamma and glycemic status in diabetes associated with chronic pancreatitis, Pancreatology 12 65-70.
|
[24]
|
S. Mitnala, P.K. Pondugala, V.R. Guduru, P. Rabella, J. Thiyyari, S. Chivukula, S. Boddupalli, A.A. Hardikar, D.N. Reddy, Reduced expression of PDX-1 is associated with decreased beta cell function in chronic pancreatitis, Pancreas 39 856-862.
|
[25]
|
J.J. Blondet, A.M. Carlson, T. Kobayashi, T. Jie, M. Bellin, B.J. Hering, M.L. Freeman, G.J. Beilman, D.E. Sutherland, The role of total pancreatectomy and islet autotransplantation for chronic pancreatitis, The Surgical clinics of North America 87 (2007) 1477-1501, x.
|
[26]
|
J.L. Argo, J.L. Contreras, M.M. Wesley, J.D. Christein, Pancreatic resection with islet cell autotransplant for the treatment of severe chronic pancreatitis, The American surgeon 74 (2008) 530-536; discussion 536-537.
|
[27]
|
D.S. Nath, T.A. Kellogg, D.E. Sutherland, Total pancreatectomy with intraportal auto-islet transplantation using a temporarily exteriorized omental vein, Journal of the American College of Surgeons 199 (2004) 994-995.
|
[28]
|
M.D. Bellin, D.E. Sutherland, Pediatric islet autotransplantation: indication, technique, and outcome, Current diabetes reports 10 (2010) 326-331.
|
[29]
|
T. Kobayashi, J.C. Manivel, A.M. Carlson, M.D. Bellin, A. Moran, M.L. Freeman, G.J. Bielman, B.J. Hering, T. Dunn, D.E. Sutherland, Correlation of histopathology, islet yield, and islet graft function after islet autotransplantation in chronic pancreatitis, Pancreas 40 (2011) 193-199.
|
[30]
|
A.C. Farney, J.S. Najarian, R.E. Nakhleh, G. Lloveras, M.J. Field, P.F. Gores, D.E. Sutherland, Autotransplantation of dispersed pancreatic islet tissue combined with total or near-total pancreatectomy for treatment of chronic pancreatitis, Surgery 110 (1991) 427-437; discussion 437-429.
|
[31]
|
R.P. Robertson, K.J. Lanz, D.E. Sutherland, D.M. Kendall, Prevention of diabetes for up to 13 years by autoislet transplantation after pancreatectomy for chronic pancreatitis, Diabetes 50 (2001) 47-50.
|
[32]
|
M. Biarnes, M. Montolio, V. Nacher, M. Raurell, J. Soler, E. Montanya, Beta-cell death and mass in syngeneically transplanted islets exposed to short- and long-term hyperglycemia, Diabetes 51 (2002) 66-72.
|
[33]
|
Y.B. Ahn, G. Xu, L. Marselli, E. Toschi, A. Sharma, S. Bonner-Weir, D.C. Sgroi, G.C. Weir, Changes in gene expression in beta cells after islet isolation and transplantation using laser-capture microdissection, Diabetologia 50 (2007) 334-342.
|
[34]
|
A.M. Davalli, L. Scaglia, D.H. Zangen, J. Hollister, S. Bonner-Weir, G.C. Weir, Early changes in syngeneic islet grafts: effect of recipient's metabolic control on graft outcome, Transplantation proceedings 27 (1995) 3238-3239.
|
[35]
|
P. Bhardwaj, S. Thareja, S. Prakash, A. Saraya, Micronutrient antioxidant intake in patients with chronic pancreatitis, Tropical gastroenterology : official journal of the Digestive Diseases Foundation 25 (2004) 69-72.
|
[36]
|
J.T. Hsu, C.N. Yeh, T.L. Hwang, H.M. Chen, Y.Y. Jan, M.F. Chen, Outcome of pancreaticoduodenectomy for chronic pancreatitis, Journal of the Formosan Medical Association = Taiwan yi zhi 104 (2005) 811-815.
|
[37]
|
S.L. Ong, G. Gravante, C.A. Pollard, M.A. Webb, S. Illouz, A.R. Dennison, Total pancreatectomy with islet autotransplantation: an overview, HPB : the official journal of the International Hepato Pancreato Biliary Association 11 (2009) 613-621.
|
[38]
|
N. Howes, M.M. Lerch, W. Greenhalf, D.D. Stocken, I. Ellis, P. Simon, K. Truninger, R. Ammann, G. Cavallini, R.M. Charnley, G. Uomo, M. Delhaye, J. Spicak, B. Drumm, J. Jansen, R. Mountford, D.C. Whitcomb, J.P. Neoptolemos, Clinical and genetic characteristics of hereditary pancreatitis in Europe, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2 (2004) 252-261.
|
[39]
|
R.W. Ammann, Diagnosis and management of chronic pancreatitis: current knowledge, Swiss medical weekly 136 (2006) 166-174.
|
[40]
|
H.E. De Cock, M.A. Forman, T.B. Farver, S.L. Marks, Prevalence and histopathologic characteristics of pan-creatitis in cats, Veterinary pathology 44 (2007) 39-49.
|
[41]
|
H. Wang, C. Ferran, C. Attanasio, F. Calise, L.E. Otterbein, Induction of protective genes leads to islet survival and function, Journal of transplantation 2011 (2011) 141898.
|
[42]
|
H. Wang, H. Wu, F. Rocuts, Z. Gu, F.H. Bach, L.E. Otterbein, Activation of Peroxisome Proliferator-activated Receptor gamma Prolongs Islet Allograft Survival, Cell transplantation (2012).
|
[43]
|
J.A. Emamaullee, A.M. Shapiro, Interventional strategies to prevent beta-cell apoptosis in islet transplantation, Diabetes 55 (2006) 1907-1914.
|
[44]
|
S.T. Grey, M.B. Arvelo, W. Hasenkamp, F.H. Bach, C. Ferran, A20 inhibits cytokine-induced apoptosis and nuclear factor kappaB-dependent gene activation in islets, The Journal of experimental medicine 190 (1999) 1135-1146.
|
[45]
|
R. Riachy, B. Vandewalle, J. Kerr Conte, E. Moerman, P. Sacchetti, B. Lukowiak, V. Gmyr, T. Bouck-enooghe, M. Dubois, F. Pattou, 1,25-dihydroxyvitamin D3 protects RINm5F and human islet cells against cytokine-induced apoptosis: implication of the antiapoptotic protein A20, Endocrinology 143 (2002) 4809-4819.
|
[46]
|
G. Christoffersson, P.O. Carlsson, M. Phillipson, Intramuscular islet transplantation promotes restored islet vascularity, Islets 3 (2011) 69-71.
|
[47]
|
G. Basta, R. Calafiore, Immunoisolation of pancre-atic islet grafts with no recipient's immunosuppression: actual and future perspectives, Current diabetes reports 11 (2011) 384-391.
|
[48]
|
A. Fort, N. Fort, C. Ricordi, C.L. Stabler, Biohybrid devices and encapsulation technologies for engineering a bioartificial pancreas, Cell transplantation 17 (2008) 997-1003.
|
[49]
|
J.A. Giraldo, J.D. Weaver, C.L. Stabler, Tissue engineering approaches to enhancing clinical islet transplantation through tissue engineering strategies, Journal of diabetes science and technology 4 (2010) 1238-1247.
|
[50]
|
N. Trivedi, M. Keegan, G.M. Steil, J. Hollister-Lock, W.M. Hasenkamp, C.K. Colton, S. Bonner-Weir, G.C. Weir, Islets in alginate macrobeads reverse diabetes despite minimal acute insulin secretory responses, Transplantation 71 (2001) 203-211.
|
[51]
|
R. van Schilfgaarde, P. de Vos, Factors influencing the properties and performance of microcapsules for immunoprotection of pancreatic islets, Journal of molecular medicine 77 (1999) 199-205.
|
[52]
|
J.O. Sandberg, N. Olsson, R.C. Johnson, C. Hellerstrom, A. Andersson, Immunosuppression, macroencapsulation and ultraviolet-B irradiation as immunoprotection in porcine pancreatic islet xenotransplantation, Pharmacology & toxicology 76 (1995) 400-405.
|
[53]
|
J.M. Pollok, C. Ibarra, C.E. Broelsch, J.P. Vacanti, [Im-muno-isolation of xenogenic islands of Langerhans in a tissue engineered autologous cartilage capsule], Zentralblatt fur Chirurgie 123 (1998) 830-833.
|
[54]
|
M. Qi, Y. Gu, N. Sakata, D. Kim, Y. Shirouzu, C. Yamamoto, A. Hiura, S. Sumi, K. Inoue, PVA hydrogel sheet macroencapsulation for the bioartificial pancreas, Biomaterials 25 (2004) 5885-5892.
|
[55]
|
Y. Teramura, H. Iwata, Islets surface modification prevents blood-mediated inflammatory responses, Bioconjug Chem 19 (2008) 1389-1395.
|
[56]
|
D.Y. Lee, S.J. Park, S. Lee, J.H. Nam, Y. Byun, Highly poly(ethylene) glycolylated islets improve long-term islet allograft survival without immunosuppressive medication, Tissue Eng 13 (2007) 2133-2141.
|
[57]
|
A. Basarkar, J. Singh, Poly (lactide-co-glycolide)-polymethacrylate nanoparticles for intramuscular delivery of plasmid encoding interleukin-10 to prevent autoimmune diabetes in mice, Pharmaceutical research 26 (2009) 72-81.
|
[58]
|
G.H. Mao, G.A. Chen, H.Y. Bai, T.R. Song, Y.X. Wang, The reversal of hyperglycaemia in diabetic mice using PLGA scaffolds seeded with islet-like cells derived from human embryonic stem cells, Biomaterials 30 (2009) 1706-1714.
|
[59]
|
R. Jain, N.H. Shah, A.W. Malick, C.T. Rhodes, Controlled drug delivery by biodegradable poly(ester) devices: different preparative approaches, Drug development and industrial pharmacy 24 (1998) 703-727.
|
[60]
|
R.A. Jain, The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices, Biomaterials 21 (2000) 2475-2490.
|
[61]
|
J.M. Lu, X. Wang, C. Marin-Muller, H. Wang, P.H. Lin, Q. Yao, C. Chen, Current advances in research and clinical applications of PLGA-based nanotechnology, Expert review of molecular diagnostics 9 (2009) 325-341.
|
[62]
|
K.A. Athanasiou, G.G. Niederauer, C.M. Agrawal, Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers, Biomaterials 17 (1996) 93-102.
|
[63]
|
D. Yin, J.W. Ding, J. Shen, L. Ma, M. Hara, A.S. Chong, Liver ischemia contributes to early islet failure following intraportal transplantation: benefits of liver ischemic-preconditioning, American journal of transplantation: official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 6 (2006) 60-68.
|
[64]
|
J.T. Wilson, E.L. Chaikof, Thrombosis and inflammation in intraportal islet transplantation: a review of pathophysiology and emerging therapeutics, Journal of diabetes science and technology 2 (2008) 746-759.
|
[65]
|
R. Cardani, A. Pileggi, C. Ricordi, C. Gomez, D.A. Baidal, G.G. Ponte, D. Mineo, R.N. Faradji, T. Froud, G. Ciancio, V. Esquenazi, G.W. Burke, 3rd, G. Selvaggi, J. Miller, N.S. Kenyon, R. Alejandro, Allosensitization of islet allograft recipients, Transplantation 84 (2007) 1413-1427.
|
[66]
|
M.R. Rickels, M. Kamoun, J. Kearns, J.F. Markmann, A. Naji, Evidence for allograft rejection in an islet transplant recipient and effect on beta-cell secretory capacity, The Journal of clinical endocrinology and metabolism 92 (2007) 2410-2414.
|
[67]
|
T. Lund, O. Korsgren, I.A. Aursnes, H. Scholz, A. Foss, Sustained reversal of diabetes following islet transplantation to striated musculature in the rat, The Journal of surgical research 160 (2010) 145-154.
|
[68]
|
A. Salazar-Banuelos, J.R. Wright, Jr., D. Sigalet, L. Benitez-Bribiesca, Pancreatic islet transplantation into the bone marrow of the rat, American journal of surgery 195 (2008) 674-678; discussion 678.
|
[69]
|
D.M. Berman, J.J. O'Neil, L.C. Coffey, P.C. Chaffanjon, N.M. Kenyon, P. Ruiz, Jr., A. Pileggi, C. Ricordi, N.S. Kenyon, Long-term survival of nonhuman primate islets implanted in an omental pouch on a biodegradable scaffold, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 9 (2009) 91-104.
|
[70]
|
D.J. van der Windt, G.J. Echeverri, J.N. Ijzermans, D.K. Cooper, The choice of anatomical site for islet transplantation, Cell transplantation 17 (2008) 1005-1014.
|
[71]
|
A. Pileggi, R.D. Molano, C. Ricordi, E. Zahr, J. Collins, R. Valdes, L. Inverardi, Reversal of diabetes by pancreatic islet transplantation into a subcutaneous, neovascularized device, Transplantation 81 (2006) 1318-1324.
|